Insights from 2023 ESMO Annual Meeting

 

Insights from 2023 ESMO Annual Meeting
Avatar

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR Inhibitor R/R Cholangiocarcinoma"

By Insights from 2023 ESMO Annual Meeting FEATURING Meredith Pelster
By Insights from 2023 ESMO Annual Meeting FEATURING Meredith Pelster
124 views
October 26, 2023
0 Comments
Login to view comments. Click here to Login
Gastrointestinal
06:40
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CHAPTER-GIST-101 Study of Pimitespib Combi…

Feat. Y. Naito
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
15:47
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Adjuvant Therapy for CRC Patients"

Feat. C. Cremolini
20:44
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Upper GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
17:24
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Lower GI Cancers"

Feat. S. Cytryn, F. Pietrantonio, G. Argiles Martinez
04:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "PEVOsq Basket Trial Evaluating the Efficac…

Feat. C. Coutzac
13:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Gastrointestinal Tumors - Lower Digestive U…

Feat. R. Dienstmann
07:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Nivo + Low Dose Ipi as 1L Therapy in Advan…

Feat. K. Muro
05:36
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The DEEPER Trial - m-FOLFOXIRI + Cetuximab…

Feat. Y. Sunakawa
17:08
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "KEYNOTE-177 5-year Follow-up - Pembro vs. …

Feat. K. Shiu
05:43
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The NICHE-3 Study on Neoadjuvant Nivo + Re…

Feat. Y. Verschoor
14:54
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…

Feat. L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
17:05
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…

Feat. A. Ohba
06:24
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Tinengotinib in Pts With Advanced, FGFR In…

Feat. M. Pelster
08:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Adagrasib +/- Cetuximab in Patients With K…

Feat. M. Pelster
03:50
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the ABC-01, -02 and -…

Feat. A. Lamarca
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan